MedPath

PlayGait: A Dynamic Exoskeleton

Not Applicable
Terminated
Conditions
Cerebral Palsy
Interventions
Device: PlayGait
Other: Baseline
Registration Number
NCT05318690
Lead Sponsor
Orthocare Innovations, LLC
Brief Summary

PlayGait is an investigational dynamic energy storage and return (ESR) lower-limb exoskeleton for young children with cerebral palsy (CP), that stores energy while the child is in the stance phase of walking and returns that energy in terminal stance and early swing phase of walking. PlayGait assists with the passive dynamics of walking through an exotendon (comprised of a spring in series with a cable). The overall objective of this investigational device is to promote correct walking patterns that encourage proper bone alignment, muscle recruitment, and strengthening during walking practice in young children with CP. The study will evaluate children with CP's activity levels in the community with and without PlayGait. The study will consist of three lab visits and two, 7-day periods at home.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
1
Inclusion Criteria
  • Age 3 - 4 years (at time of informed consent)
  • Hemiplegic cerebral palsy
  • If child uses an ankle-foot orthosis (AFO), parent/caregiver is willing to have the child stop wearing their prescribed AFO during data collections (lab sessions and two 7-day periods at home)
  • Ability to walk at least 10 meters without the use of assistive devices or AFOs
  • Ability to walk at least 1 minute without the use of assistive devices or AFOs
  • Stiff knee gait - less than normal knee flexion during swing phase
  • Hip flexion passive range of motion contracture less than 20 degrees
  • Gross Motor Function Classification System (GMFCS) Levels I-II
  • Modified Ashworth Scale (MAS) <=2 for the gastrocnemius soleus, rectus femoris, and hamstrings
  • Family has resources to attend all study sessions (transportation, schedule)
  • Ability to speak and understand in English
Exclusion Criteria
  • Orthopedic surgery in the last year
  • Foster children or wards of the state
  • Use wheelchair or stroller mobility as their primary method of independent mobility
  • Severe visual impairment such that the visual impairment itself functionally limits mobility
  • Phenol or Botox injections to the legs in the last 3 months
  • Uncontrolled seizure disorder, defined as any seizure in the last 3 months that influenced mobility skills and function (seizures which did not affect mobility are acceptable)
  • Lower limb fracture in the last 3 months
  • Planned surgery or changes to movement disorder medication during the study period
  • Inability to understand directions sufficiently to complete the study assessments
  • Cognitive, behavioral, or any other issues that may not allow for effective study participation
  • Unwilling to complete the study protocol

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
PlayGait (Exoskeleton)PlayGaitExperimental lower-limb device.
BaselineBaselineBaseline condition without using any prescribed lower-limb orthoses.
Primary Outcome Measures
NameTimeMethod
Cadence7 days with baseline condition; 7 days with PlayGait condition

Low, medium, and high activity rate

Shifts in cadence7 days with baseline condition; 7 days with PlayGait condition

Shifts from low to medium cadence and shifts from medium to high cadence

Secondary Outcome Measures
NameTimeMethod
1 minute walk test1st lab session (baseline); 3rd lab session with PlayGait after 7 days of wearing PlayGait

The distance walked in one minute

10 meter walk test1st lab session (baseline); 3rd lab session with PlayGait after 7 days of wearing PlayGait

The time it takes to walk 10 meters

Time of PlayGait usePlayGait condition: 7 days in the community with PlayGait

Amount of time each day that PlayGait is worn

Average steps per dayBaseline Condition: 7 days in the community without PlayGait (no lower-limb assistive devices); PlayGait condition: 7 days with PlayGait

Step count per day

Pediatric Balance Scale1st lab session (baseline); 3rd lab session with PlayGait after 7 days of wearing PlayGait

Participant completes 14 activity items that measure pediatric balance

Trial Locations

Locations (1)

Orthocare Innovations, LLC

🇺🇸

Edmonds, Washington, United States

© Copyright 2025. All Rights Reserved by MedPath